cell signaling technology 7f5 Search Results


anti p53 7f5 antibody  (Addgene inc)
93
Addgene inc anti p53 7f5 antibody
Anti P53 7f5 Antibody, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+technology+7f5/pm39945347-245-3-45?v=Addgene+inc
Average 93 stars, based on 1 article reviews
anti p53 7f5 antibody - by Bioz Stars, 2026-08
93/100 stars
  Buy from Supplier
p53  (Proteintech)
96
Proteintech p53
a Representative images showing the SOX2 (green) and <t>p53</t> (red) in control (WT) and mutant (V190G) day 15 organoids. Scale bar, 50μm. b . Quantification of nuclear p53 signal of individual neuroepithelial bud at day 15 control (WT) and mutant (V190G) organoids. Unpaired t-test with Welch’s correction. n = 16 control and 17 mutant imaged regions from 3 independent batches, error bars are SEM. c . UMAP embedding of a subset of the organoid development at days 10 and 15 coloured by time point and genotype. d . Expression of individual p53 target genes in cells from control (WT) and mutant (V190G) samples.
P53, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+technology+7f5/pmc12339376-410-51-70?v=Proteintech
Average 96 stars, based on 1 article reviews
p53 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier
p53 7f5  (Santa Cruz Biotechnology)
96
Santa Cruz Biotechnology p53 7f5
Apoptosis induction and cell cycle progression in A2780, A2780cis, shTRC1-, and shGDF15-A2780cis tumors after long-term carboplatin treatment. n = 3 tumors were pooled in each group. (A) Immunoblot of p16 INK 4A , p21 Waf1/Cip1 , p27 Kip1 , PCNA, and GAPDH. (B) Percent <t>p53</t> activity measured by phospho-p53 normalized to total p53 electroluminescence. (C, D) Levels of cleaved PARP and cleaved caspase-3 measured by electroluminescence.
P53 7f5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cell+signaling+technology+7f5/pmc04329009-51-13-25?v=Santa+Cruz+Biotechnology
Average 96 stars, based on 1 article reviews
p53 7f5 - by Bioz Stars, 2026-08
96/100 stars
  Buy from Supplier

Image Search Results


a Representative images showing the SOX2 (green) and p53 (red) in control (WT) and mutant (V190G) day 15 organoids. Scale bar, 50μm. b . Quantification of nuclear p53 signal of individual neuroepithelial bud at day 15 control (WT) and mutant (V190G) organoids. Unpaired t-test with Welch’s correction. n = 16 control and 17 mutant imaged regions from 3 independent batches, error bars are SEM. c . UMAP embedding of a subset of the organoid development at days 10 and 15 coloured by time point and genotype. d . Expression of individual p53 target genes in cells from control (WT) and mutant (V190G) samples.

Journal: Nature Cell Biology

Article Title: A programmed decline in ribosome levels governs human early neurodevelopment

doi: 10.1038/s41556-025-01708-8

Figure Lengend Snippet: a Representative images showing the SOX2 (green) and p53 (red) in control (WT) and mutant (V190G) day 15 organoids. Scale bar, 50μm. b . Quantification of nuclear p53 signal of individual neuroepithelial bud at day 15 control (WT) and mutant (V190G) organoids. Unpaired t-test with Welch’s correction. n = 16 control and 17 mutant imaged regions from 3 independent batches, error bars are SEM. c . UMAP embedding of a subset of the organoid development at days 10 and 15 coloured by time point and genotype. d . Expression of individual p53 target genes in cells from control (WT) and mutant (V190G) samples.

Article Snippet: Primary antibodies used in this study include anti-PAX6 (BioLegend, 90130, 1:200 dilution), BLBP (Abcam, ab32423, 1:200 dilution), ZEB2 (Origene, TA802113, 1:150 dilution), ZO1 (BD Biosciences, 610966, 1:300 dilution), GFP (R&D systems, AF4240, 1:200 dilution), HSP60 (ptglab, 15282-1-AP, 1:200 dilution), VIM(V9) (Thermo Fisher, MA5-11883, 1:250 dilution), KI67 (Thermo Fisher, 14-5698-82, 1:100 dilution), p53 (7F5), (Cell Signalling, 2527S, 1:500 dilution), OCT3/4 (SCBT; sc-5279, 1:100 dilution), SOX2(E4) (SCBT, sc-365823, 1:50 dilution) and RSL24D1 (Proteintech, 25190-1-AP, 1:100 dilution).

Techniques: Control, Mutagenesis, Expressing

Apoptosis induction and cell cycle progression in A2780, A2780cis, shTRC1-, and shGDF15-A2780cis tumors after long-term carboplatin treatment. n = 3 tumors were pooled in each group. (A) Immunoblot of p16 INK 4A , p21 Waf1/Cip1 , p27 Kip1 , PCNA, and GAPDH. (B) Percent p53 activity measured by phospho-p53 normalized to total p53 electroluminescence. (C, D) Levels of cleaved PARP and cleaved caspase-3 measured by electroluminescence.

Journal: Cancer Medicine

Article Title: Knockdown of platinum-induced growth differentiation factor 15 abrogates p27-mediated tumor growth delay in the chemoresistant ovarian cancer model A2780cis

doi: 10.1002/cam4.354

Figure Lengend Snippet: Apoptosis induction and cell cycle progression in A2780, A2780cis, shTRC1-, and shGDF15-A2780cis tumors after long-term carboplatin treatment. n = 3 tumors were pooled in each group. (A) Immunoblot of p16 INK 4A , p21 Waf1/Cip1 , p27 Kip1 , PCNA, and GAPDH. (B) Percent p53 activity measured by phospho-p53 normalized to total p53 electroluminescence. (C, D) Levels of cleaved PARP and cleaved caspase-3 measured by electroluminescence.

Article Snippet: The following primary rabbit anti-human antibodies were used: AKT (4685), phospho-AKT (Ser473) (4060), p53 (7F5) (9284), phospho-p53 (Ser15) (2527), p21 Waf1/Cip1 (12D) (2947), cyclin D1 (Santa Cruz, sc-718), Bcl-2 (2870), PCNA (2586), and GAPDH (2118), all purchased from Cell Signaling unless indicated otherwise.

Techniques: Western Blot, Activity Assay